scalable synthesis of fmoc-protected galnac-threonine ... · synthesis of threonine acceptor 13 ....
TRANSCRIPT
![Page 1: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/1.jpg)
Scalable Synthesis of Fmoc-Protected GalNAc-Threonine Amino Acid and TN Antigen via Nickel Catalysis
Fei Yu, † Matthew S. McConnell, † and Hien M. Nguyen*
Department of Chemistry, University of Iowa, Iowa City, IA 52246
S1
![Page 2: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/2.jpg)
Table of Contents
Methods and Reagents Page S3 General Procedures Page S3 – S7 Analytical Data of All Compounds Page S4 – S11
NMR Spectra of 1 Page S13
NMR Spectra of 8 Page S14 NMR Spectra of 13 Page S15
NMR Spectra of 14 Page S16 – S17
NMR Spectra of 15 Page S18 – S19 NMR Spectra of A Page S20 NMR Spectra of 16 Page S21 NMR Spectra of 17 Page S22 – S23 NMR Spectra of 18 Page S24 – S25 NMR Spectra of 19 Page S26 – S27 NMR Spectra of 20 Page S28 – S29 NMR Spectra of 21 Page S30 – S31 NMR Spectra of 22 Page S32 – S33
S2
![Page 3: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/3.jpg)
Supporting Information
Methods and Reagents. All reactions were performed in oven-dried Schlenk flasks fitted with glass stoppers under a positive pressure of argon. Organic solutions were concentrated by rotary evaporation below 40 oC at 25 torr. Analytical thin-layer chromatography (TLC) was routinely used to monitor the progress of the reactions and performed using pre-coated glass plates with 230-400 mesh silica gel impregnated with a fluorescent indicator (250 nm). Visualization was achieved using UV light, iodine, or ceric ammonium molybdate. Flash chromatography was performed and employed 230-400 mesh silica gel. Dichloromethane was distilled from calcium hydride under an argon atmosphere at 760 torr. All other chemicals were obtained from commercial vendors and used without further purification. Instrumentation. All proton (1H) nuclear magnetic resonance spectra were recorded on 300, 400, and 500 MHz spectrometers. All carbon (13C) nuclear magnetic resonance spectra were recorded on 75, 100, 125, 150 MHz) NMR spectrometer. Chemical shifts are expressed in parts per million (δ scale) downfield from tetramethylsilane and are referenced to the residual proton in the NMR solvent (CDCl3: δ 7.27 ppm, δ 77.23 ppm; DMSO-d6: δ 2.50 ppm, δ 39.52 ppm; D2O: δ 4.79 ppm). Data are presented as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, and bs = broad singlet), integration, and coupling constant in hertz (Hz). Infrared (IR) spectra were reported in cm-1. High resolution (ESI) mass spectrometry was performed to identify the purity of the compounds. Preparation of Ni Catalyst – Ni(F-Ph-CN)4Cl2 A 100 mL Schlenk flask was charged with anhydrous NiCl2 (1.0 g, 7.71 mmol, 1.0 equiv), 4-fluorobenzonitrile (25.0 g, 206.6 mmol, 26.8 equiv), and anhydrous dichloromethane (10 mL). The reaction mixture was stirred vigorously at room temperature 48 h, transferred to a flask containing hexanes (150 mL), and stirred for 30 min. The mixture was then left unperturbed for 10 min, and the colorless supernatant liquid was removed. Hexanes (150 mL) was added to the precipitate and stirred for 5 min. The mixture was then left unperturbed for 10 min and the colorless supernatant liquid was removed. This process was repeated one more time. Finally the yellow precipitate was dried under high vacuum at 100 oC for 24 h (456.7 mg). Synthesis of threonine acceptor 13
HOCO2Allyl
Me
NHFmoc
13
HOCO2H
Me
NHFmocBr
DIPEADMF
A 100 mL oven-dried Schlenk flask was charged with Fmoc-Thr-OH (3 g, 8.788 mmol, 1.0 equiv), allyl bromide (1.50 mL, 17.577 mmol, 2.00 equiv), DIPEA (3.10
S3
![Page 4: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/4.jpg)
mL, 17.577 mmol, 2.00 equiv), and anhydrous DMF (35 mL). The resulting mixture was stirred at room temperature overnight. The reaction mixture was diluted with ethyl acetate (150 mL) and washed with brine (4 x 40 mL). The organic layer was dried with anhydrous sodium sulfate and concentrated to a white solid. The crude product was purified by flash chromatography on silica gel (hexane/ethyl acetate = 2/1) to afford 13 as a white solid (2.70 g, 80%). 1H NMR (CDCl3, 300 MHz): δ = 7.79 – 7.30 (m, 8H), 5.99 – 5.86 (m, 2H), 5.35 (d, J = 17.1 Hz, 1H), 5.26 (d, J = 11.7 Hz, 1H), 4.69 (d, J = 5.7 Hz, 2H), 4.46 – 4.40 (m, 4H), 4.28 – 4.24 (m, 1H), 2.74 (bs, 1H), 1.28 (d, J = 6.3 Hz, 3H). The 1H NMR Spectrum of 13 is matched with previously published results.i Synthesis of galactosamine imidate donor 16 (Large Scale) The former synthetic route for making galactosamine donor 16 was deemed to inefficient for large scale preparation.ii A more streamlined synthetic route is shown below.
1. NH3, MeOH1.
2. Ac2O
A
O
ClH3NHO
OH
OHOHCHO
CF3
O
NAcO OAc
OAcAcO
CF3
O
NAcO
O CF3
NPh
OAcAcO
CF3
16
Cl
NPh
Ph2.
C(2)-N-ortho-Trifluoromethylbenzylideneamino-D-Galactosaminepyranoside A. An oven dried 1 L round bottom flask was charged with D-Galactosamine hydrochloride (23.0 g, 1067 mmol, 1 equiv), 2-(trifluoromethyl)-benzaldehyde (42.2 mL, 320.0 mmol, 3.0 equiv), anhydrous pyridine (213 mL), and triethylamine (22.3 mL, 160.05 mmol, 1.5 equiv). The resulting mixture was stirred at 60 oC for 24 h. The reaction mixture was cooled to room temperature, and acetic anhydride (81.3 mL, 853.6 mmol, 8.0 equiv) was added. The reaction mixture was then stirred at room temperature overnight and concentrated to a dark oil. The crude product was purified by flash chromatography on silica gel (hexane/ethyl acetate = 5/1 → 3/1 with 1% Et3N) to afford A as a white solid (12.55 g, 55%). 1H NMR (CDCl3, 300 MHz): δ = 8.67 (d, J = 2.1 Hz, 1H), 8.06 (d, J = 7.2 Hz, 1H), 7.70 – 7.67 (m, 1H), 7.61 – 7.51 (m, 2H), 5.98 (d, J = 8.1 Hz, 1H), 5.46 (d, J = 3.3 Hz, 1H), 5.30 (dd, J = 10.5, 3.6 Hz, 1H), 4.23 – 4.15 (m, 3H), 3.72 (dd, J = 10.5, 8.4 Hz, 1H), 2.19 (s, 3H), 2.05 (s, 3H), 2.04 (s, 3H), 1.91 (s, 3H). The 1H NMR spectrum of A matches our previously published result in the Journal of Organic Chemistry, 2012, 77, 7330-7343.
S4
![Page 5: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/5.jpg)
Galactosaminepyranosyl N-Phenyl Trifluoroacetimidate 16. A 500 mL round bottom flask was charged with A (12.55 g, 24.36 mmol, 1 equiv) and anhydrous THF (125 mL). The solution was cooled to 0 oC, ammonia in methanol solution (7 N, 53.4 mL, 373.96 mmol, 15.0 equiv) was added. The resulting mixture was stirred at room temperature for 2.5 h and monitored by TLC. The round bottom flask was unsealed, and the reaction mixture was stirred under positive air flow for 1 h. The reaction mixture was concentrated to a yellow oil, and the crude hemiacetal used in the next step without further purification. A 250 mL round bottom flask was charged with the yellow-oil hemiacetal, 2,2,2-trifluoro-N-phenyl-ethanimidoyl chloride (4.4 mL, 27.3 mmol, 1.1 equiv), diazobicycloundecane (DBU) (2.0 mL, 13.65 mmol, 0.5 equiv) and anhydrous dichloromethane (53 mL). The resulting solution was stirred at room temperature overnight. When the reaction mixture was complete as monitored by TLC (hexane/ethyl acetate = 1/1), the reaction mixture was evaporated and purified by flash chromatography on silica gel (hexane/ethyl acetate = 5/1 → 3/1 with 1% Et3N) to afford 16 as a white solid (6.30 g, 40%; α:β = 1:2). 1H NMR (CDCl3, 300 MHz): δ = 8.73 (d, J = 2.4 Hz, 1H), 8.12 (d, J = 7.5 Hz, 1H), 7.73 (d, J = 6.9 Hz, 1H), 7.67 – 7.56 (m, 2H), 7.31 (t, J = 7.5 Hz, 2H), 7.13 (t, J = 7.2 Hz, 1H), 6.82 (d, J = 7.8 Hz, 2H), 6.73 (d, J = 7.8 Hz, 0.25H), 6.02 (bs, 0.75H), 5.45 (d, J = 3.0 Hz, 1H), 5.28 (bs, 1H), 4.22 (d, J = 6.0 Hz, 2H), 4.06 (bs, 1H), 3.85 (t, J = 9.3 Hz, 1H), 2.24 (s, 3H), 2.06 (s, 3H), 1.94 (s, 3H).
The 1H NMR spectrum of 16 matches our previously published result in the Journal of Organic Chemistry, 2012, 77, 7330-7343. General Glycosylation Procedure Using Ni(4-F-PhCN)4(OTf)2 as the Catalyst (Batch A and Batch B)
O
NAcO
AcO OAc
OCO2Allyl
Me
NHFmoc
CF3
HOCO2Allyl
Me
NHFmoc
10 mol %
Ni(4-F-PhCN)4(OTf)2,
CH2Cl2, 35 oC, 12 h
O
NAcO
O CF3
NPh
OAcAcO
CF3
16 (1.0 equiv.) 13
(1.20 equiv) 15
Batch A:
A 100 mL oven-dried Schlenk flask was charged with Ni(4-F-PhCN)4Cl2 (78.6 mg, 0.128 mmol, 10 mol%) and AgOTf (65.8 mg, 0.256 mmol, 20 mol%) in dichloromethane (4 mL). The resulting mixture was stirred at room temperature for 30 min. A solution of D-galactosamine N-phenyl trifluoroacetimidate donor 16 (808 mg, 1.278 mmol, 1.0 equiv), threonine acceptor 13 (585 mg, 1.534 mmol, 1.20 equiv), and CH2Cl2 (4.5 mL) was added. The resulting mixture was stirred under argon at 35 oC overnight. The reaction mixture was filtered through Celite and then purified by silica
S5
![Page 6: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/6.jpg)
gel flash chromatography (3/1, hexanes/ethyl acetate + 1% triethylamine) to give the desired glycosyl amino acid 15 (783 mg, 74%, α only).
1H NMR (CDCl3, 300 MHz): δ = 8.68 (d, J = 2.1 Hz, 1H), 8.39 (d, J = 2.4 Hz, 1H), 7.79 – 7.60 (m, 9H), 7.49 – 7.30 (m, 10H), 6.21 (d, J = 9.0 Hz, 1H), 6.10 (s, 1H), 5.80 – 5.68 (m, 1H), 5.53 – 5.47 (m, 2H), 5.21 – 5.13 (m, 2H), 5.03 (d, J = 3.3 Hz, 1H), 4.53 – 4.40 (m, 6H), 4.34 – 4.24 (m, 2H), 4.19 (d, J = 6.6 Hz, 2H), 3.86 (dd, J = 10.5, 3.9 Hz, 1H), 2.21 (s, 3H), 2.10 (s, 3H), 1.91 (s, 3H), 1.44 (d, J = 6.3 Hz, 3H). 13C NMR (CDCl3, 100 MHz): δ = 170.4, 170.2, 170.2, 161.9, 156.8, 143.9, 143.8, 141.2, 132.2, 131.2, 130.7, 129.1, 128.7, 127.7, 127.1, 127.1, 125.3 (q, JC-F = 5.4 Hz), 121.0, 119.9, 119.0, 100.0, 77.2, 75.3, 68.2, 68.0, 67.6, 67.2, 67.0, 66.0, 62.1, 58.8, 47.2, 20.8, 20.7, 20.4, 19.3. IR (film, cm-1): ν = 3154, 2982, 2892, 1746, 1471, 1378, 1315, 1245, 1173, 1095, 911. HRMS (ESI): calc. for C42H44N2O12F3 (M+H): 825.2846; found: 825.2850. Batch B:
A 100 mL oven-dried Schlenk flask was charged with Ni(4-F-PhCN)4Cl2 (92.0 mg, 0.15 mmol, 10 mol%) and AgOTf (77.0 mg, 0.30 mmol, 20 mol%) in dichloromethane (5 mL). The resulting mixture was stirred at room temperature for 30 min. A solution of D-galactosamine N-phenyl trifluoroacetimidate donor 16 (947 mg, 1.5 mmol, 1.0 equiv), threonine acceptor 13 (685 mg, 1.8 mmol, 1.20 equiv), and CH2Cl2 (5 mL) was added. The resulting mixture was stirred under argon at 35 oC overnight. The reaction mixture was filtered through Celite and then purified by silica gel flash chromatography* (3/1, hexanes/ethyl acetate + 1% triethylamine) to give the desired glycosyl amino acid 15 (779 mg, 63%, α only).
* We first tried to separate the crude product 15 from unreacted threonine residue
13 by automated chromatography on a Teledyne Isco CombiFlash Rf system utilizing normal phase pre-column cartridges and gold high performance columns. However, it was not successful. Thus, the product 15 was then purified by manual silica gel flash chromatography. General Glycosylation Procedure Using Ni(4-F-PhCN)4(OTf)2 as the Catalyst (Batch C)
O
NAcO
AcO OAc
OCO2Allyl
Me
NHFmoc
CF3
HOCO2Allyl
Me
NHFmoc
10 mol %
Ni(4-F-PhCN)4(OTf)2,
CH2Cl2, 35 oC, 12 h
O
NAcO
O CF3
NPh
OAcAcO
CF3
16 (1.28 equiv.) 13
(1.0 equiv) 15
S6
![Page 7: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/7.jpg)
A 100 mL oven-dried Schlenk flask was charged with Ni(4-F-PhCN)4Cl2 (434.7
mg, 0.71 mmol, 10 mol%) and AgOTf (363.8 mg, 1.42 mmol, 20 mol%) in dichloromethane (23 mL). The resulting mixture was stirred at room temperature for 30 min. A solution of D-galactosamine N-phenyl trifluoroacetimidate donor 16 (5.73 g, 9.059 mmol, 1.28 equiv), threonine acceptor 13 (2.7 g, 7.078 mmol, 1.0 equiv), and CH2Cl2 (24 mL) was added. The resulting mixture was stirred under argon at 35 oC overnight. The reaction mixture was filtered through Celite and then purified by silica gel flash chromatography (3/1, hexanes/ethyl acetate + 1% triethylamine) to give the desired glycosyl amino acid 15 (3.77 g, 66%, α only). General Glycosylation Procedure Using Ni(4-F-PhCN)4(OTf)2 as the Catalyst (Small Scale)
O
NAcO
AcO OAc
OCO2Bn
Me
NHCbz
CF3
HOCO2Bn
Me
NHCbz
10 mol %
Ni(4-F-PhCN)4(OTf)2,
CH2Cl2, 35 oC, 12 h
O
NAcO
O CF3
NPh
OAcAcO
CF3
16 (1 equiv.) 1.2 equiv 21 (α
only)
A 10 mL oven-dried Schlenk flask was charged with D-galactosamine N-phenyl
trifluoroacetimidate donor 16 (93.0 mg, 0.147 mmol, 1.0 equiv), Z-Thr-OBzl (60.6 mg, 0.176 mmol, 1.2 equiv), and CH2Cl2 (0.5 mL). A preformed solution of Ni(4-F-PhCN)4(OTf)2, which was generated in situ from Ni(4-F-PhCN)4Cl2 (9.0 mg, 0.0147 mmol, 10 mol%) and AgOTf (7.6 mg, 0.0294 mmol, 20 mol%) in dichloromethane (0.5 mL) was then added to the solution. The resulting mixture was stirred under argon at 35 oC overnight, and purified by silica gel flash chromatography (3/1, hexanes/ethyl acetate + 1% triethylamine) to give the desired disaccharide 21 (76.0 mg, 67%, α only).
1H NMR (CDCl3, 500 MHz): δ = 8.56 (s, 1H), 8.25 (d, J = 7.5 Hz, 1H), 7.63 (d, J = 8.0 Hz, 1H), 7.42 – 7.15 (m, 10H), 6.09 (d, J = 9.0 Hz, 1H), 5.47 (d, J = 2.0 Hz, 1H), 5.38 (dd, J = 10.5, 3.0 Hz, 1H), 5.21 – 5.13 (m, 2H), 5.01 – 4.89 (m, 2H), 4.83 (d, J = 4.0 Hz, 1H), 4.51 (dd, J = 12.5, 6.5 Hz, 1H), 4.40 (d, J = 7.0 Hz, 2H), 4.15 (d, J = 7.0 Hz, 2H), 3.70 (dd, J = 15.0, 3.5 Hz, 1H), 2.20 (s, 3H), 2.07 (s, 3H), 1.87 (s, 3H), 1.39 (d, J = 6.5 Hz, 3H). 13C NMR (CDCl3, 100 MHz): δ = 170.4, 170.1, 169.9, 161.7, 156.9, 136.3, 135.0, 133.1, 132.2, 130.6, 129.0, 129.0, 128.7, 128.5, 128.3, 128.2, 128.1, 125.5, 125.3 (q, JC-F = 5.4 Hz), 122.8, 99.6, 74.9, 68.1, 67.7, 67.2, 67.1, 66.9, 62.1, 58.7, 53.4, 20.7, 20.7, 20.3, 19.4. IR (film, cm-1): ν = 3432, 3342, 3064, 3031, 2925, 2251, 1728, 1638, 1495, 1376, 1315, 1229, 1166, 1066, 1017. HRMS (ESI): calc. for C39H42N2O12F3 (M+H): 787.2690; found: 787.2709.
S7
![Page 8: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/8.jpg)
O
NAcO
AcO OAc
OCO2Bn
Me
NHFmoc
CF3
17
1H NMR (CDCl3, 400 MHz): δ = 8.60 (s, 1 H), 8.37-8.26 (m, 2 H), 7.82-7.18 (m, 15 H), 6.30 (d, J = 8.8 Hz, 1 H), 5.51-5.42 (m, 2 H), 5.00 (d, J = 12.0 Hz, 1 H), 4.91 (d, J = 12. Hz, 1 H), 4.87 (d, J = 2.4 Hz, 1 H), 4.55-4.37 (m, 4 H), 4.30 (t, J = 7.2 Hz, 1 H), 4.22 (d, J = 7.2 Hz, 1 H), 4.15 (d, J = 6.4 Hz, 2 H), 3.74 (dd, J = 3.2, 10.4 Hz, 1 H), 2.20 (s, 3 H), 2.06 (s, 3 H), 1.89 (s, 3 H), 1.40 (d, J = 6.4 Hz, 3 H). 13C NMR (CDCl3, 100 MHz): δ = 170.5, 170.3, 170.2 170.0, 161.9, 156.9, 155.0, 143.81, 143.75, 141.2, 135.3, 130.7, 129.3, 128.5, 128.4, 128.3, 127.67, 127.66, 127.1, 126.2, 125.24, 125.19, 120.6, 119.9, 99.9, 75.3, 68.1, 67.9, 67.6, 67.2, 67.1, 66.9, 62.1, 58.8, 47.1, 20.7, 20.6, 20.3, 19.2. IR (film, cm-1): ν = 3323, 1747, 1641, 1314. HRMS (ESI): calc. for C46H46F3N2O12 (M+H): 875.3003; found: 875.3026.
O
NAcO
AcO OAc
O
Me
NHFmoc
CF3
18
O
O
1H NMR (CDCl3, 400 MHz): δ = 8.67 (s, 1 H), 8.36 (d, J = 7.6 Hz, 1 H), 7.82-7.27 (m, 11 H), 6.37 (d, J = 8.8 Hz, 1 H), 5.5-5.44 (m, 2 H), 5.07 (d, J = 2.4 Hz, 1 H), 4.58-4.40 (m, 6 H), 4.328-4.25 (m, 2 H), 4.19 (d, J = 6.4 Hz, 2 H), 3.85 (dd, J = 3.6, 10.4 Hz, 1 H), 2.40 (s, 1 H), 2.21 (s, 3 H), 2.09 (s, 3 H), 1.90 (s, 3 H), 1.45 (d, J = 6.4 Hz, 3 H). 13C NMR (CDCl3, 100 MHz): δ = 170.4, 170.1, 169.9, 169.7, 162.1, 156.8, 143.8, 143.7, 141.1, 133.1, 132.2, 130.7, 129.0, 127.63, 127.61, 127.0, 125.5 (q, JC-F = 5.4 Hz), 125.22, 125.18, 119.9, 100.0, 75.5, 75.4, 68.0, 67.5, 67.1, 66.9, 62.1, 58.7, 52.6, 47.0, 20.73, 20.65, 20.3, 19.1. IR (film, cm-1): ν = 3328, 1738, 1643, 1316. HRMS (ESI): calc. for C42H42F3N2O12 (M+H): 823.2690; found: 823.2705.
S8
![Page 9: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/9.jpg)
O
NBnO
BnO OAc
OCO2Allyl
Me
NHFmoc
CF3
19
1H NMR (CDCl3, 400 MHz): δ = 8.78 (s, 1 H), 8.41 (d, J = 6.8 Hz, 1 H), 7.82-7.22 (m, 21 H), 6.38 (d, J = 8.8 Hz, 1 H), 5.76-5.66 (m, 1 H), 5.18-5.07 (m, 2 H), 4.99 (d, J = 11.6 Hz, 1 H), 4.93 (d, J = 3.2 Hz, 1 H), 4.69-4.55 (m, 3 H), 4.38-4.02 (m, 14 H), 3.96 (s, 1 H), 2.04 (s, 3 H), 1.39 (d, J = 6.4 Hz, 3 H). 13C NMR (CDCl3, 100 MHz): δ = 170.6, 170.1, 161.3, 156.8, 143.8, 141.2, 138.1, 138.0, 132.0, 131.2, 130.4, 128.7, 128.40, 128.37, 128.2, 127.8, 127.7, 126, 127.4, 127.0, 125.5 (q, JC-F = 5.4 Hz), 125.2, 119.9, 118.9, 100.6, 75.1, 74.6, 73.2, 72.4, 70.8, 69.4, 67.3, 65.9, 63.9, 58.9, 47.2, 20.8, 19.2. IR (film, cm-1): ν = 3341, 1727, 1313.. HRMS (ESI): calc. for C52H52F3N2O10 (M+H): 921.3574; found: 921.3590.
O
NBnO
BnO OAc
OCO2Bn
Me
NHFmoc
CF3
20 1H NMR (CDCl3, 400 MHz): δ = 8.76 (d, J = 1.6 Hz, 1 H), 8.42 (d, J = 6.4 Hz, 1 H), 7.83-7.17 (m, 26 H), 6.39 (d, J = 7.2 Hz, 1 H), 5.05-4.85 (m, 4 H), 4.62-3.92 (m, 14 H), 2.04 (s, 3 H), 1.37 (d, J = 6.0 Hz, 3 H). 13C NMR (CDCl3, 100 MHz): δ = 170.6, 170.2, 161.3, 156.8, 143.84, 143.77, 141.2, 138.1, 138.0, 134.9, 133.5, 131.9, 130.4, 128.8, 128.7, 128.6, 128.5, 128.40, 128.37, 128.24, 128.19, 127.8, 127.7, 127.6, 127.5, 127.4, 127.0, 125.5 (q, JC-F = 5.4 Hz), 119.9, 100.7, 75.2, 74.6, 73.1, 72.4, 70.6, 69.4, 67.3, 67.1, 65.9, 63.9, 59.0, 47.2, 20.8, 19.1., IR (film, cm-1): ν = 3342, 1727, 1313. HRMS (ESI): calc. for C56H54F3N2O10 (M+H): 971.3731; found: 971.3756.
O
NAcO
AcO OAc
OCO2Allyl
Me
NHFmoc
14F3C
S9
![Page 10: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/10.jpg)
1H NMR (CDCl3, 500 MHz): δ = 8.13 (d, J = 8.0 Hz, 1H), 8.04 (d, J = 8.0 Hz, 1.5H), 7.92 – 7.81 (m, 4H), 7.75 – 7.65 (m, 5H), 6.25 (d, J = 8.0 Hz, 0.5H), 6.10 (d, J = 3.5 Hz, 1H), 5.62 (dd, J = 10, 3.0 Hz, 1H), 5.60 – 5.54 (m, 2H), 5.50 (s, 1H), 5.47 (bs, 1H), 5.44 (bs, 1.5H), 5.14 (d, J = 1.0 Hz, 1H), 4.71 (t, J = 6.5 Hz, 1H), 4.55 – 4.52 (m, 2.5H), 4.31 – 4.08 (m, 9H), 3.77 (t, J = 7.0 Hz, 2H), 3.14 (d, J = 6.0 Hz, 2H), 2.18 (s, 3H), 2.15 (s, 3H), 2.11 (s, 1.5H), 2.10 (s, 1.5H), 2.09 (s, 3H), 1.94 (s, 1.5H), 1.92 (s, 3H), 1.46 – 1.43 (m, 4.5H) 13C NMR (CDCl3, 100 MHz): δ = 189.2, 189.0, 183.6, 169.8, 163.7, 161.8, 161.1, 156.6, 155.4, 134.4, 131.1, 130.3, 129.9, 129.9, 128.9, 128.7, 128.5, 126.1, 125.7, 122.7, 119.1, 100.0, 99.5, 93.8, 90.1, 88.5, 86.1, 85.4, 69.8, 68.4, 67.6, 66.5, 61.3, 57.2, 55.1, 53.4, 51.1, 50.2, 42.6, 30.9, 29.7, 26.4, 22.7, 21.4, 20.7. IR (film, cm-1): ν = 3156, 2992, 2896, 1747, 1474, 1377, 1315, 1243, 1171, 1095, 909. HRMS (ESI): calc. for C42H44N2O12F3 (M+H): 825.2846; found: 825.2864.
O
AcHNAcO
OCO2Allyl
Me
NHFmoc
OAcAcO
22 An oven dried 250 mL round bottom flask was charged with 15 (3.77 g, 4.57 mmol, 1 equiv), anhydrous methanol (57 mL), and acetyl chloride (520 µL, 7.32 mmol, 1.6 equiv). The resulting mixture was stirred at room temperature overnight. Pyridine (40 mL) was added, and the reaction mixture was concentrated to a yellow oil. The yellow oil was then placed under high vacuum for 2 h to remove trace methanol. The yellow oil was dissolved in anhydrous pyridine (46 mL). Acetic anhydride (3.5 mL, 36.56 mmol, 8.0 equiv) was added to the solution. The reaction mixture was stirred at room temperature overnight and then concentrated to afford crude 22. The resulting residue was purified by silica gel flash chromatography (1/1 hexane/ethyl acetate → 1/2 hexane/ethyl acetate) to provide pure 22 (2.25 g, 70%) as a yellow solid. 1H NMR (CDCl3, 400 MHz): δ = 7.79 (d, J = 7.2 Hz, 2H), 7.65 (d, J = 7.6 Hz, 2H), 7.44 – 7.33 (m, 4H), 5.94 – 5.84 (m, 1H), 5.77 (d, J = 10.4 Hz, 1H), 5.58 (d, J = 9.6 Hz, 1H), 5.41 – 5.30 (m, 4H), 5.10 (dd, J = 11.6, 3.2 Hz, 1H), 4.90 (d, J = 3.2 Hz, 1H), 4.69 (dd, J = 13.2, 7.2 Hz, 1H), 4.62 – 4.56 (m, 3H), 4.46 (dd, J = 7.6, 4.0 Hz, 2H), 4.31 – 4.22 (m, 3H), 4.16 – 4.07 (m, 3H), 2.18 (s, 3H), 2.06 (s, 3H), 2.02 (s, 6H), 1.35 (d, J = 6.4 Hz, 3H). 13C NMR (CDCl3, 100 MHz): δ = 170.9, 170.6, 170.3, 170.3, 156.5, 143.8, 143.6, 141.3, 130.8, 127.8, 127.1, 125.1, 125.1, 120.1, 120.0, 100.1, 68.4, 67.5, 67.3, 66.4, 62.1, 58.5, 53.4, 47.5, 47.1, 29.7, 23.2, 20.7, 20.6, 18.2. IR (film, cm-1): ν = 3432, 3145, 2933, 2843, 2251, 1744, 1670, 1499, 1372, 1229, 1037. HRMS (ESI): calc. for C36H43N2O13 (M+H): 711.2765; found: 711.2771
S10
![Page 11: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/11.jpg)
O
AcHNAcO
OCO2H
Me
NHFmoc
OAcAcO
8 A 250 mL oven-dried round bottom flask was charged with glycosyl amino acid 22 (1.12 g, 1.576 mmol, 1 equiv) and anhydrous tetrahydrofuran (44 mL). The solution was cooled to 0 oC, N-methylaniline (838.8 µL, 7.75 mmol, 4.92 equiv) and tetrakis(triphenylphosphine)palladium (179 mg, 0.155 mmol, 0.098 equiv) were then added. The resulting mixture was stirred at room temperature while being monitored by TLC. After 1 h, the reaction mixture was concentrated to a dark oil and purified by silica gel flash chromatography (9/1, dichloromethane/methanol) to provide pure 8 (1.02 g, 97%) as an off-white solid.
1H NMR (CDCl3, 500 MHz): δ = 7.78 – 7.31 (m, 10H), 5.40 (s, 1H), 5.31 – 5.26 (m, 1H), 5.15 (d, J = 7.5 Hz, 1H), 5.02 (d, J = 27 Hz, 1H), 4.59 – 4.42 (m, 4H), 4.29 – 4.25 (m, 3H), 4.20 (d, J = 5.0 Hz, 1H), 4.14 – 4.09 (m, 3H), 2.18 (s, 3H), 2.05 (s, 3H), 2.01 (s, 3H), 1.99 (s, 3H), 1.29 (d, J = 13 Hz, 3H). The 1H NMR spectrum of 8 matches the result obtained by Sigma-Aldrich website.
O
AcHNHO
OCO2H
Me
NH2
OHHO
1 An oven dried 250 mL round bottom flask was charged with 15 (1.50 g, 1.82 mmol, 1 equiv), anhydrous methanol (23 mL), and acetyl chloride (207 µL, 2.91 mmol, 1.6 equiv). The reaction mixture was stirred at room temperature overnight. Pyridine (20 mL) was added, and the reaction mixture was concentrated to a yellow oil. The yellow oil was then placed under high vacuum for 2 h to remove trace methanol. The yellow oil was dissolved in anhydrous pyridine (20 mL). Acetic anhydride (1.39 mL, 14.6 mmol, 8.0 equiv) was added to the reaction mixture. The reaction mixture was stirred at room temperature overnight. The reaction mixture was concentrated to afford crude 22. The resulting residue was purified by silica gel flash chromatography (1/1 hexane/ethyl acetate → 1/2 hexane/ethyl acetate) to provide pure 22 (1.18 g, 91%) as a yellow solid.
S11
![Page 12: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/12.jpg)
An oven dried 100 mL round bottom flask was charged with 22 (1.18 g, 1.67 mmol, 1 equiv), sodium hydroxide (0.2 M in methanol) (33.4 mL, 6.680 mmol, 4.00 equiv), and triethylamine (1.16 mL, 8.350 mmol, 5.00 equiv). The resulting mixture was stirred at room temperature overnight. The reaction mixture was concentrated to a yellow oil. The yellow oil was washed with dichloromethane (3 x 5 mL). The residue was redissolved in water and brought to neutral pH using Amberlyst 15 hydrogen form. The aqueous solution was decanted and lyophilized to a white solid 1 (0.51 g, 99%). 1H NMR (CDCl3, 300 MHz): δ = 4.85 (d, J = 3.9 Hz, 1H), 4.32 (dd, J = 6.9, 2.1 Hz, 1H), 4.02 (dd, J = 7.5, 3.6 Hz, 1H), 3.94 (t, J = 6.3 Hz, 1H), 3.87 (d, J = 2.7 Hz, 1H), 3.76 (dd, J = 8.1, 3.0 Hz, 1H), 3.66 – 3.61 (m, 3H) 1.95 (s, 3H), 1.30 (d, J = 6.6 Hz, 1H). The 1H NMR Spectrum of 1 is matched with previously published results.iii
i Albers, M. F.; van Vliet, B. and Hedberg, C. Org. Lett. 2011, 13, 6014-6017. ii Yu, F. and Nguyen, H. M. J. Org. Chem. 2012, 77, 7330-7343. iii Sarkar, S.; Lombardo, S. A.; Herner, D. N.; Talan, R. S.; Wall, K. A. and Suchek, S. J. J. Am. Chem. Soc. 2010, 132, 17236 – 17246. † The authors contributed equally to the present work
S12
![Page 13: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/13.jpg)
1.21.31.41.51.61.71.81.92.02.12.22.32.42.52.62.72.82.93.03.13.23.33.43.53.63.73.83.94.04.14.24.34.44.54.64.74.84.95.0f1 (ppm)
2.89
3.26
3.47
1.24
1.24
1.29
1.01
0.98
1.00
1.28
81.
310
1.95
1
3.60
53.
612
3.62
33.
634
3.63
93.
651
3.66
23.
741
3.75
13.
778
3.78
83.
866
3.87
53.
915
3.93
73.
958
4.00
24.
014
4.03
94.
051
4.28
14.
288
4.30
34.
310
4.32
64.
333
4.34
84.
355
4.84
94.
862
300 MHz
S13
![Page 14: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/14.jpg)
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.44.64.85.05.25.45.65.86.06.26.46.66.87.07.27.47.67.88.0f1 (ppm)
4.43
9.54
3.54
2.98
1.22
3.24
4.63
1.44
1.05
0.97
1.00
5.42
1.32
1.77
3.38
1.28
21.
308
1.98
82.
006
2.05
22.
175
4.09
44.
113
4.12
94.
140
4.19
24.
202
4.25
24.
265
4.27
84.
291
4.41
64.
466
4.48
44.
518
4.53
64.
556
4.58
74.
981
5.07
15.
144
5.16
95.
262
5.28
45.
310
5.40
5
7.31
07.
323
7.39
67.
405
7.42
07.
445
7.45
97.
472
7.50
17.
625
7.63
97.
741
7.76
37.
778
500 MHz
S14
![Page 15: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/15.jpg)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0f1 (ppm)
3.17
1.00
1.28
3.83
2.47
1.27
1.25
2.22
4.96
2.04
2.55
1.27
61.
297
2.74
4
4.23
54.
259
4.28
24.
402
4.42
74.
445
4.45
64.
682
4.70
15.
245
5.28
45.
330
5.38
75.
864
5.88
35.
918
5.93
85.
957
5.97
45.
993
7.27
67.
302
7.32
77.
351
7.39
37.
418
7.44
37.
635
7.65
27.
768
7.79
3
S15
![Page 16: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/16.jpg)
1.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.44.64.85.05.25.45.65.86.06.26.46.66.87.07.27.47.67.88.08.2f1 (ppm)
4.25
2.33
1.53
3.99
2.72
6.70
1.93
1.71
8.86
2.27
0.98
0.86
2.50
0.90
2.00
0.99
1.00
0.54
5.18
4.44
1.37
1.06
1.43
01.
443
1.45
71.
917
1.94
12.
089
2.09
62.
110
2.15
02.
177
3.13
03.
142
3.76
94.
079
4.08
64.
100
4.10
74.
116
4.13
04.
139
4.15
34.
174
4.17
74.
187
4.19
64.
210
4.24
14.
253
4.26
04.
271
4.27
64.
293
4.51
74.
712
5.14
35.
145
5.43
65.
475
5.50
05.
542
5.54
95.
567
5.58
45.
591
5.59
75.
612
5.61
95.
633
5.63
96.
098
6.10
57.
647
7.66
47.
682
7.70
47.
721
7.73
27.
747
7.81
47.
835
7.85
17.
881
7.89
77.
908
7.92
48.
033
8.04
98.
123
8.13
9
S16
![Page 17: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/17.jpg)
30405060708090100110120130140150160170180190f1 (ppm)
20.7
21.4
22.7
26.4
29.7
30.9
42.6
50.2
51.1
53.4
55.1
57.2
61.3
66.5
67.6
68.4
69.8
85.4
86.1
88.5
90.1
93.8
99.5
100.
0
119.
112
2.7
125.
712
6.1
128.
512
8.7
128.
912
8.9
129.
912
9.9
130.
313
1.1
134.
4
155.
415
6.6
161.
116
1.8
163.
716
9.8
183.
618
9.0
189.
2
S17
![Page 18: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/18.jpg)
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5f1 (ppm)
3.19
3.44
3.88
3.67
1.16
2.68
2.48
6.77
1.00
2.31
2.32
1.20
1.13
0.91
9.53
8.96
1.11
1.28
1.43
41.
455
1.90
72.
094
2.21
53.
837
3.84
93.
871
3.88
44.
181
4.20
24.
259
4.28
44.
318
4.34
34.
401
4.42
94.
438
4.46
14.
470
4.49
14.
511
4.53
35.
021
5.03
25.
126
5.15
75.
210
5.49
55.
534
6.09
56.
196
6.22
67.
299
7.30
37.
316
7.32
07.
324
7.32
87.
341
7.34
57.
365
7.37
07.
390
7.39
47.
406
7.40
97.
415
7.42
37.
431
7.46
67.
478
7.49
07.
603
7.62
77.
657
7.66
57.
687
7.69
67.
698
7.70
27.
724
7.73
77.
742
7.76
67.
792
8.36
78.
394
8.68
3
S18
![Page 19: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/19.jpg)
102030405060708090100110120130140150160170f1 (ppm)
19.3
20.4
20.7
20.8
47.2
58.8
62.1
66.0
67.0
67.2
67.6
68.0
68.2
75.3
77.2
100.
011
9.0
119.
912
1.0
125.
212
5.3
125.
512
7.1
127.
112
7.7
128.
712
9.1
130.
713
1.2
132.
214
1.2
143.
814
3.9
156.
8
161.
9
170.
217
0.2
170.
4
S19
![Page 20: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/20.jpg)
2.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0f1 (ppm)
2.98
6.02
2.97
0.96
3.00
0.97
1.01
1.00
2.18
1.11
1.03
1.04
1.90
52.
041
2.05
12.
189
3.69
13.
718
3.72
53.
753
4.15
14.
160
4.17
64.
192
4.23
3
5.27
75.
288
5.31
15.
323
5.45
65.
467
5.96
55.
992
7.51
47.
539
7.55
97.
566
7.58
97.
610
7.67
07.
676
7.69
98.
055
8.07
9
8.65
88.
665
S20
![Page 21: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/21.jpg)
2.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0f1 (ppm)
3.23
2.98
3.17
1.00
0.85
2.23
0.88
1.04
0.76
0.29
1.86
1.15
1.85
2.39
1.17
0.95
1.06
1.93
72.
057
2.23
5
3.82
03.
849
3.88
04.
057
4.21
54.
235
5.27
55.
459
5.46
9
6.02
0
6.72
26.
748
6.80
96.
835
7.10
27.
127
7.15
17.
283
7.31
07.
335
7.56
17.
584
7.61
87.
643
7.66
87.
722
7.74
58.
106
8.13
1
8.72
68.
734
S21
![Page 22: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/22.jpg)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0f1 (ppm)
0.0E+00
5.0E+06
1.0E+07
1.5E+07
2.0E+07
2.5E+07
3.0E+07
3.5E+07
4.0E+07
4.5E+07
5.0E+071H DRX-400 BBO probe, , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
2.73
3.02
3.11
3.19
0.91
1.98
1.09
0.93
3.94
1.91
1.00
1.91
0.84
15.8
5
2.40
0.98
1.39
1.41
1.89
2.06
2.20
3.72
3.73
3.75
3.76
4.15
4.16
4.41
4.43
4.43
4.86
4.87
4.89
4.92
4.98
5.48
5.50
5.51
6.29
6.32
7.38
7.57
7.59
7.75
7.77
8.33
8.34
8.60
8.61
S22
![Page 23: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/23.jpg)
0102030405060708090100110120130140150160170180190200f1 (ppm)
-2.0E+08
0.0E+00
2.0E+08
4.0E+08
6.0E+08
8.0E+08
1.0E+09
1.2E+09
1.4E+09
1.6E+09
1.8E+09
2.0E+09
2.2E+09
2.4E+09
2.6E+091H DRX-400 BBO probe, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
19.2
120
.33
20.6
220
.69
47.1
0
58.8
062
.11
66.9
267
.10
67.1
967
.53
67.9
168
.10
75.2
976
.69
77.0
077
.32
99.8
7
119.
8912
0.53
125.
1712
5.22
126.
2112
7.05
127.
6412
7.65
128.
2412
8.38
128.
4612
9.24
130.
7013
5.24
141.
1814
3.73
143.
78
154.
9915
6.92
161.
93
169.
9317
0.19
170.
2817
0.49
S23
![Page 24: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/24.jpg)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.5f1 (ppm)
-1.00E+07
0.00E+00
1.00E+07
2.00E+07
3.00E+07
4.00E+07
5.00E+07
6.00E+07
7.00E+07
8.00E+07
9.00E+07
1.00E+08
1.10E+08
1.20E+08
1.30E+08
1.40E+08
1.50E+081H DRX-400 BBO probe, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
3.17
2.95
3.30
3.47
1.19
0.98
2.10
1.04
1.04
6.34
1.00
2.15
0.94
10.7
1
1.03
1.09
1.44
1.46
1.90
2.09
2.21
2.40
3.83
3.84
3.86
3.87
4.18
4.20
4.26
4.48
4.49
4.54
4.55
5.06
5.07
5.50
5.53
5.54
6.36
6.38
7.28
7.39
7.40
7.61
7.63
7.77
7.79
8.36
8.37
8.67
S24
![Page 25: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/25.jpg)
0102030405060708090100110120130140150160170180190f1 (ppm)
-2.00E+08
-1.00E+08
0.00E+00
1.00E+08
2.00E+08
3.00E+08
4.00E+08
5.00E+08
6.00E+08
7.00E+08
8.00E+08
9.00E+08
1.00E+09
1.10E+09
1.20E+09
1.30E+09
1.40E+09
1.50E+09
1.60E+09
1.70E+09
1.80E+09
1.90E+09
2.00E+091H DRX-400 BBO probe, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
19.1
520
.36
20.6
620
.74
47.0
4
52.6
3
58.7
262
.09
66.8
667
.11
67.4
968
.04
75.4
375
.50
76.6
877
.00
77.3
2
100.
03
119.
8712
5.18
125.
2212
7.04
127.
6112
8.96
130.
7413
2.19
141.
1414
3.66
143.
75
156.
77
162.
07
169.
7016
9.89
170.
1417
0.43
S25
![Page 26: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/26.jpg)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.5f1 (ppm)
-5.0E+06
0.0E+00
5.0E+06
1.0E+07
1.5E+07
2.0E+07
2.5E+07
3.0E+07
3.5E+07
4.0E+07
4.5E+07
5.0E+07
5.5E+07
6.0E+07
6.5E+07
7.0E+07
7.5E+07
8.0E+07
8.5E+071H DRX-400 BBO probe, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
2.80
2.99
14.3
1
3.33
0.96
1.00
2.00
0.88
0.75
20.8
3
0.85
0.93
1.38
1.40
2.05
3.95
3.96
4.13
4.36
4.61
4.63
4.93
4.94
4.98
5.01
5.10
5.12
5.69
5.71
6.36
6.38
7.24
7.28
7.36
7.78
7.80
8.41
8.42
8.43
8.78
8.79
S26
![Page 27: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/27.jpg)
102030405060708090100110120130140150160170180190200f1 (ppm)
-5.0E+08
0.0E+00
5.0E+08
1.0E+09
1.5E+09
2.0E+09
2.5E+09
3.0E+09
3.5E+09
4.0E+09
4.5E+09
5.0E+09
5.5E+09
1H DRX-400 BBO probe, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
19.2
020
.78
47.1
6
58.9
263
.93
65.9
367
.27
69.3
970
.75
72.4
173
.16
74.5
875
.11
76.6
877
.00
77.3
2
100.
62
118.
9011
9.93
127.
3812
7.66
128.
2312
8.36
128.
39
137.
9713
8.07
141.
1914
3.80
156.
84
161.
30
170.
0617
0.64
S27
![Page 28: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/28.jpg)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0f1 (ppm)
-1.00E+07
0.00E+00
1.00E+07
2.00E+07
3.00E+07
4.00E+07
5.00E+07
6.00E+07
7.00E+07
8.00E+07
9.00E+07
1.00E+08
1.10E+08
1H DRX-400 BBO probe, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
3.00
3.51
14.4
3
4.56
0.95
1.98
24.7
3
0.95
0.94
S28
![Page 29: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/29.jpg)
0102030405060708090100110120130140150160170180190200f1 (ppm)
-1.00E+09
0.00E+00
1.00E+09
2.00E+09
3.00E+09
4.00E+09
5.00E+09
6.00E+09
7.00E+09
8.00E+09
9.00E+09
1.00E+10
1.10E+10
1.20E+10
1.30E+101H DRX-400 BBO probe, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
19.1
220
.78
47.1
559
.01
63.9
467
.14
67.2
869
.36
70.6
572
.37
73.1
474
.56
75.2
776
.68
77.0
077
.20
77.3
277
.32
100.
68
119.
9212
5.15
127.
0012
7.38
127.
5212
7.65
127.
8312
8.17
128.
3512
8.38
128.
4413
0.41
137.
9614
1.19
156.
87
161.
29
170.
1817
0.63
S29
![Page 30: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/30.jpg)
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5f1 (ppm)
2.84
2.78
3.26
2.92
0.94
2.02
1.83
0.83
1.00
1.79
1.98
0.93
0.95
0.79
2.52
3.09
4.91
1.00
0.80
0.90
1.39
51.
408
1.86
92.
073
2.19
9
3.68
23.
689
3.70
33.
710
4.14
34.
157
4.39
34.
407
4.49
34.
502
4.51
54.
527
4.82
74.
835
4.88
74.
912
4.98
35.
007
5.13
15.
155
5.18
65.
211
5.36
75.
374
5.38
95.
395
5.47
55.
479
6.08
26.
100
7.15
27.
166
7.18
17.
196
7.21
17.
245
7.25
77.
272
7.28
67.
369
7.40
17.
416
7.62
47.
640
8.25
08.
265
8.56
1
S30
![Page 31: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/31.jpg)
102030405060708090100110120130140150160170180f1 (ppm)
19.4
20.3
20.7
20.7
53.4
58.7
62.1
66.9
67.1
67.2
67.7
68.1
74.9
99.6
122.
812
5.2
125.
312
5.3
125.
412
5.5
128.
112
8.2
128.
312
8.5
128.
512
8.7
129.
012
9.0
130.
613
2.2
133.
113
5.0
136.
315
6.9
161.
716
9.9
170.
117
0.4
S31
![Page 32: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/32.jpg)
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.44.64.85.05.25.45.65.86.06.26.46.66.87.07.27.47.67.88.0f1 (ppm)
3.01
6.15
3.96
3.68
3.63
3.32
2.89
2.76
1.11
1.00
1.25
2.05
1.64
0.96
0.93
1.18
2.29
2.30
1.96
2.18
1.34
31.
359
2.01
62.
055
2.17
64.
065
4.09
24.
105
4.10
94.
123
4.14
14.
159
4.22
04.
236
4.25
44.
271
4.28
74.
306
4.46
04.
467
4.47
64.
486
4.55
54.
562
4.57
64.
588
4.60
74.
617
4.66
54.
680
4.69
54.
713
4.89
34.
901
5.08
25.
090
5.11
15.
119
5.12
85.
304
5.33
05.
346
5.38
85.
400
5.40
75.
571
5.59
55.
769
5.79
55.
844
5.85
95.
872
5.88
55.
901
5.91
25.
927
7.33
07.
337
7.34
87.
355
7.36
77.
373
7.40
67.
424
7.44
17.
646
7.66
57.
785
7.80
3
S32
![Page 33: Scalable Synthesis of Fmoc-Protected GalNAc-Threonine ... · Synthesis of threonine acceptor 13 . HO CO 2Allyl Me NHFmoc 13 HO CO 2H Me NHFmoc Br DIPEA DMF. A 100 mL oven-dried Schlenk](https://reader035.vdocuments.us/reader035/viewer/2022062917/5ed002bbfbcce83357125f7b/html5/thumbnails/33.jpg)
102030405060708090100110120130140150160170f1 (ppm)
18.2
20.6
20.7
23.2
29.7
47.1
47.5
53.4
58.5
62.1
66.4
67.3
67.5
68.4
100.
1
120.
012
0.1
125.
112
5.1
127.
112
7.8
130.
8
141.
314
3.6
143.
8
156.
5
170.
317
0.3
170.
617
0.9
S33